Key result
Saline volume expansion raises plasma ANF and urinary cyclic GMP without altering tissue kallikrein.
Why the study?
The relationship between plasma atrial natriuretic factor and urinary excretion of sodium, cyclic GMP, and tissue kallikrein during acute volume expansion was unclear.
Does acute volume expansion with saline alter plasma Ir-ANF and urinary cyclic GMP or tissue kallikrein in healthy female volunteers?
Does acute volume expansion with saline alter plasma Ir-ANF and urinary cyclic GMP or tissue kallikrein in healthy female volunteers?
Urinary cyclic GMP follows the plasma Ir-ANF response to acute volume expansion with saline, suggesting it may be a useful marker of ANF activity.
Answers are grounded in this paper and cite their sources.
May support urinary cGMP as ANF marker during volume expansion; hypothesis-generating, needs validation before clinical use.
The relationship between plasma immunoreactive atrial natriuretic factor (Ir-ANF) and the urinary excretion of sodium, guanosine 3′:5′-cyclic monophosphate (cyclic GMP) and of tissue kallikrein was examined in seven healthy female volunteers. 2. Each volunteer attended on two occasions, a control and a saline infusion day. On the infusion day saline (2 litres, 0.9% NaCl) was administered over 60 min. Measurements of plasma Ir-ANF and urinary excretion of sodium, cyclic GMP and of tissue kallikrein were made at 30 min intervals during the infusion and for 3 h after the infusion. 3. Mean (± sem) urinary sodium excretion increased from a basal value (time 0) of 102 ±15 μmol/min to 222 ± 47 μmol/min 60–90 min from the start of the infusion and thereafter remained significantly elevated (P < 0.01) above sodium excretion on the control day. 4. In response to saline infusion there was a transient rise in mean (± sem) plasma Ir-ANF from 6.7 ± 0.8 pmol/l to a peak of 22.5 ±3.7 pmol/l at 75 min, falling to 12.7 ± 1.9 pmol/l at 135 min. The peak plasma Ir-ANF level on the infusion day was significantly elevated (P < 0.05) above the time-matched measurement on the control day. 5. Similarly, there was a transient rise in mean (± sem) urinary cyclic GMP excretion on the infusion day from 30.9 ±4.4 fmol/min to 64.6 ± 11.4 fmol/min during the 60–90 min collection period, returning to 43.7 ± 14.5 fmol/min at 210–240 min. Cyclic GMP excretion on the infusion day was significantly elevated (P < 0.05) above the time-matched measurement on the control day during the period 60–180 min. 6. Serum and urinary tissue kallikrein on the infusion day did not differ significantly from time-matched measurements on the control day. 7. Thus urinary cycle GMP but not tissue kallikrein follows the plasma Ir-ANF response to acute volume expansion with saline, and may be a useful marker of the activity of this peptide.
No takes yet. Share an insight, caveat, or question.
Lewis et al. (1988) studied Healthy (n=7). Saline infusion vs. Control day was evaluated on Urinary cyclic GMP excretion (p=<0.05). Acute volume expansion with saline increased plasma Ir-ANF and urinary cyclic GMP excretion, but not tissue kallikrein.
Synapse has enriched 10 related papers. Consider them for comparative context: